U-Blot® Research Grade OleclumabCat. No. WA3268Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade OleclumabCat. No. WA3268
U-Blot® Research Grade OlaratumabCat. No. WA3267
U-Blot® Research Grade OlamkiceptCat. No. WA3266
U-Blot® Research Grade OgalvibartCat. No. WA3265
U-Blot® Research Grade OfatumumabCat. No. WA3264
U-Blot® Research Grade OfatumumabCat. No. WA3263
U-Blot® Research Grade OdulimomabCat. No. WA3262
U-Blot® Research Grade OdronextamabCat. No. WA3261
U-Blot® Research Grade OdesivimabCat. No. WA3260
U-Blot® Research Grade OcrelizumabCat. No. WA3259
U-Blot® Research Grade OciperlimabCat. No. WA3258
U-Blot® Research Grade OcaratuzumabCat. No. WA3257